I-Mab Biopharma
IMAB
#9150
Rank
โ‚ฌ72.03 M
Marketcap
0,88ย โ‚ฌ
Share price
-3.17%
Change (1 day)
-37.13%
Change (1 year)

I-Mab Biopharma (IMAB) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ0.17 Billion

According to I-Mab Biopharma's latest financial reports the company has โ‚ฌ0.17 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

I-Mab Biopharma - Cash on Hand chart (from 2024 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚ฌ0.46 B-21.33%
2021-12-31โ‚ฌ0.59 B-0.75%
2020-12-31โ‚ฌ0.59 B299.57%
2019-12-31โ‚ฌ0.14 B-36.25%
2018-12-31โ‚ฌ0.23 B218.68%
2017-12-31โ‚ฌ73.55 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ15.69 M-91.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.38 B 120.40%๐Ÿ‡บ๐Ÿ‡ธ USA